Global Hepatocyte Growth Factor Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Hepatocyte Growth Factor Market
Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Due to the COVID-19 pandemic, the global Hepatocyte Growth Factor market size is estimated to be worth US$ 60 million in 2022 and is forecast to a readjusted size of US$ 287.9 million by 2028 with a CAGR of 30.0% during the review period. Fully considering the economic change by this health crisis, Phase III (Ongoing) accounting for % of the Hepatocyte Growth Factor global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Oncology segment is altered to an % CAGR throughout this forecast period.

Asia Pacific will be the largest region of Hepatocyte Growth Factor, which will occupy about 60% market share in 2030. North America will be the second largest market with the consumption market share of 25% in 2030. ViroMed, AnGes MG, M3 Biotechnology, AVEO Pharmaceuticals, Molecular Partners and Yooyoung Pharm are the major manufacturers of industry.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Phase III (Ongoing)

Phase II (Approved)

Phase II (Ongoing)

Phase 1

Preclinical

Segment by Application

Oncology

Cardiovascular

Central Nervous System

Hematological Disorders

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Hepatocyte Growth Factor market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

ViroMed

AnGes MG

M3 Biotechnology

AVEO Pharmaceuticals

Molecular Partners

Yooyoung Pharm

F-star

Galaxy Biotech

Kringle Pharma

TABLE OF CONTENT

1 Study Coverage
1.1 Hepatocyte Growth Factor Product Introduction

1.2 Market by Type

1.2.1 Global Hepatocyte Growth Factor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Phase III (Ongoing)

1.2.3 Phase II (Approved)

1.2.4 Phase II (Ongoing)

1.2.5 Phase 1

1.2.6 Preclinical

1.3 Market by Application

1.3.1 Global Hepatocyte Growth Factor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Central Nervous System

1.3.5 Hematological Disorders

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Hepatocyte Growth Factor Sales Estimates and Forecasts 2017-2028

2.2 Global Hepatocyte Growth Factor Revenue Estimates and Forecasts 2017-2028

2.3 Global Hepatocyte Growth Factor Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Hepatocyte Growth Factor Sales by Region

2.4.1 Global Hepatocyte Growth Factor Sales by Region (2017-2022)

2.4.2 Global Sales Hepatocyte Growth Factor by Region (2023-2028)

2.5 Global Hepatocyte Growth Factor Revenue by Region

2.5.1 Global Hepatocyte Growth Factor Revenue by Region (2017-2022)

2.5.2 Global Hepatocyte Growth Factor Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Hepatocyte Growth Factor Sales by Manufacturers

3.1.1 Global Top Hepatocyte Growth Factor Manufacturers by Sales (2017-2022)

3.1.2 Global Hepatocyte Growth Factor Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatocyte Growth Factor in 2021

3.2 Global Hepatocyte Growth Factor Revenue by Manufacturers

3.2.1 Global Hepatocyte Growth Factor Revenue by Manufacturers (2017-2022)

3.2.2 Global Hepatocyte Growth Factor Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Hepatocyte Growth Factor Revenue in 2021

3.3 Global Hepatocyte Growth Factor Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Hepatocyte Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Hepatocyte Growth Factor Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Hepatocyte Growth Factor Sales by Type

4.1.1 Global Hepatocyte Growth Factor Historical Sales by Type (2017-2022)

4.1.2 Global Hepatocyte Growth Factor Forecasted Sales by Type (2023-2028)

4.1.3 Global Hepatocyte Growth Factor Sales Market Share by Type (2017-2028)

4.2 Global Hepatocyte Growth Factor Revenue by Type

4.2.1 Global Hepatocyte Growth Factor Historical Revenue by Type (2017-2022)

4.2.2 Global Hepatocyte Growth Factor Forecasted Revenue by Type (2023-2028)

4.2.3 Global Hepatocyte Growth Factor Revenue Market Share by Type (2017-2028)

4.3 Global Hepatocyte Growth Factor Price by Type

4.3.1 Global Hepatocyte Growth Factor Price by Type (2017-2022)

4.3.2 Global Hepatocyte Growth Factor Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Hepatocyte Growth Factor Sales by Application

5.1.1 Global Hepatocyte Growth Factor Historical Sales by Application (2017-2022)

5.1.2 Global Hepatocyte Growth Factor Forecasted Sales by Application (2023-2028)

5.1.3 Global Hepatocyte Growth Factor Sales Market Share by Application (2017-2028)

5.2 Global Hepatocyte Growth Factor Revenue by Application

5.2.1 Global Hepatocyte Growth Factor Historical Revenue by Application (2017-2022)

5.2.2 Global Hepatocyte Growth Factor Forecasted Revenue by Application (2023-2028)

5.2.3 Global Hepatocyte Growth Factor Revenue Market Share by Application (2017-2028)

5.3 Global Hepatocyte Growth Factor Price by Application

5.3.1 Global Hepatocyte Growth Factor Price by Application (2017-2022)

5.3.2 Global Hepatocyte Growth Factor Price Forecast by Application (2023-2028)

6 North America

6.1 North America Hepatocyte Growth Factor Market Size by Type

6.1.1 North America Hepatocyte Growth Factor Sales by Type (2017-2028)

6.1.2 North America Hepatocyte Growth Factor Revenue by Type (2017-2028)

6.2 North America Hepatocyte Growth Factor Market Size by Application

6.2.1 North America Hepatocyte Growth Factor Sales by Application (2017-2028)

6.2.2 North America Hepatocyte Growth Factor Revenue by Application (2017-2028)

6.3 North America Hepatocyte Growth Factor Market Size by Country

6.3.1 North America Hepatocyte Growth Factor Sales by Country (2017-2028)

6.3.2 North America Hepatocyte Growth Factor Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Hepatocyte Growth Factor Market Size by Type

7.1.1 Europe Hepatocyte Growth Factor Sales by Type (2017-2028)

7.1.2 Europe Hepatocyte Growth Factor Revenue by Type (2017-2028)

7.2 Europe Hepatocyte Growth Factor Market Size by Application

7.2.1 Europe Hepatocyte Growth Factor Sales by Application (2017-2028)

7.2.2 Europe Hepatocyte Growth Factor Revenue by Application (2017-2028)

7.3 Europe Hepatocyte Growth Factor Market Size by Country

7.3.1 Europe Hepatocyte Growth Factor Sales by Country (2017-2028)

7.3.2 Europe Hepatocyte Growth Factor Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Hepatocyte Growth Factor Market Size by Type

8.1.1 Asia Pacific Hepatocyte Growth Factor Sales by Type (2017-2028)

8.1.2 Asia Pacific Hepatocyte Growth Factor Revenue by Type (2017-2028)

8.2 Asia Pacific Hepatocyte Growth Factor Market Size by Application

8.2.1 Asia Pacific Hepatocyte Growth Factor Sales by Application (2017-2028)

8.2.2 Asia Pacific Hepatocyte Growth Factor Revenue by Application (2017-2028)

8.3 Asia Pacific Hepatocyte Growth Factor Market Size by Region

8.3.1 Asia Pacific Hepatocyte Growth Factor Sales by Region (2017-2028)

8.3.2 Asia Pacific Hepatocyte Growth Factor Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Hepatocyte Growth Factor Market Size by Type

9.1.1 Latin America Hepatocyte Growth Factor Sales by Type (2017-2028)

9.1.2 Latin America Hepatocyte Growth Factor Revenue by Type (2017-2028)

9.2 Latin America Hepatocyte Growth Factor Market Size by Application

9.2.1 Latin America Hepatocyte Growth Factor Sales by Application (2017-2028)

9.2.2 Latin America Hepatocyte Growth Factor Revenue by Application (2017-2028)

9.3 Latin America Hepatocyte Growth Factor Market Size by Country

9.3.1 Latin America Hepatocyte Growth Factor Sales by Country (2017-2028)

9.3.2 Latin America Hepatocyte Growth Factor Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Hepatocyte Growth Factor Market Size by Type

10.1.1 Middle East and Africa Hepatocyte Growth Factor Sales by Type (2017-2028)

10.1.2 Middle East and Africa Hepatocyte Growth Factor Revenue by Type (2017-2028)

10.2 Middle East and Africa Hepatocyte Growth Factor Market Size by Application

10.2.1 Middle East and Africa Hepatocyte Growth Factor Sales by Application (2017-2028)

10.2.2 Middle East and Africa Hepatocyte Growth Factor Revenue by Application (2017-2028)

10.3 Middle East and Africa Hepatocyte Growth Factor Market Size by Country

10.3.1 Middle East and Africa Hepatocyte Growth Factor Sales by Country (2017-2028)

10.3.2 Middle East and Africa Hepatocyte Growth Factor Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 ViroMed

11.1.1 ViroMed Corporation Information

11.1.2 ViroMed Overview

11.1.3 ViroMed Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 ViroMed Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 ViroMed Recent Developments

11.2 AnGes MG

11.2.1 AnGes MG Corporation Information

11.2.2 AnGes MG Overview

11.2.3 AnGes MG Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 AnGes MG Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 AnGes MG Recent Developments

11.3 M3 Biotechnology

11.3.1 M3 Biotechnology Corporation Information

11.3.2 M3 Biotechnology Overview

11.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 M3 Biotechnology Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 M3 Biotechnology Recent Developments

11.4 AVEO Pharmaceuticals

11.4.1 AVEO Pharmaceuticals Corporation Information

11.4.2 AVEO Pharmaceuticals Overview

11.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 AVEO Pharmaceuticals Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 AVEO Pharmaceuticals Recent Developments

11.5 Molecular Partners

11.5.1 Molecular Partners Corporation Information

11.5.2 Molecular Partners Overview

11.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Molecular Partners Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Molecular Partners Recent Developments

11.6 Yooyoung Pharm

11.6.1 Yooyoung Pharm Corporation Information

11.6.2 Yooyoung Pharm Overview

11.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Yooyoung Pharm Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Yooyoung Pharm Recent Developments

11.7 F-star

11.7.1 F-star Corporation Information

11.7.2 F-star Overview

11.7.3 F-star Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 F-star Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 F-star Recent Developments

11.8 Galaxy Biotech

11.8.1 Galaxy Biotech Corporation Information

11.8.2 Galaxy Biotech Overview

11.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Galaxy Biotech Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Galaxy Biotech Recent Developments

11.9 Kringle Pharma

11.9.1 Kringle Pharma Corporation Information

11.9.2 Kringle Pharma Overview

11.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Kringle Pharma Hepatocyte Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Kringle Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Hepatocyte Growth Factor Industry Chain Analysis

12.2 Hepatocyte Growth Factor Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Hepatocyte Growth Factor Production Mode & Process

12.4 Hepatocyte Growth Factor Sales and Marketing

12.4.1 Hepatocyte Growth Factor Sales Channels

12.4.2 Hepatocyte Growth Factor Distributors

12.5 Hepatocyte Growth Factor Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Hepatocyte Growth Factor Industry Trends

13.2 Hepatocyte Growth Factor Market Drivers

13.3 Hepatocyte Growth Factor Market Challenges

13.4 Hepatocyte Growth Factor Market Restraints

14 Key Findings in The Global Hepatocyte Growth Factor Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample